Днк наномеханические роботы и вычислительные устройства

Вид материалаДокументы
Подобный материал:
1   ...   5   6   7   8   9   10   11   12   ...   15
37. P.656–663.
  • Hannon G.J., Rossi J.J. Unlocking the potential of the human genome with RNA interference // Nature. 2004. V.431. P.371–378.
  • Hansen J.B., Westergaard M., Thrue C.A., Giwercman B., Oerum H. Antisense knockdown of PKC-alpha using LNA-oligos. Nucleosides Nucleotides // Nucleic Acids. 2003. V.22. P.1607–1609.
  • Hansen M.R., Mueller L., Pardi A. Tunable alignment of macromolecules by filamentous phage yields dipolar coupling interactions // Nat. Struct. Biol. 1998. V.5. P.1065–1074.
  • Hanson S., Bauer G., Fink B., Suess B. Molecular analysis of a synthetic tetracycline-binding riboswitch // RNA. 2005. V.11. P.503-511.
  • Hanson S., Berthelot K., Fink B., McCarthy J.E., Suess B. Tetracycline-aptamer-mediated translational regulation in yeast // Mol. Microbiol. 2003. V.49. P.1627–1637.
  • Harada K, Frankel A.D. Identification of two novel arginine binding DNAs // EMBO J. 1995. V.14. P.5798–5811.
  • Hartig J.S., Grüne I., Najafi-Shoushtari S.H., Famulok M. Sequence-specific detection of MicroRNAs by signal-amplifying ribozymes // J. Am. Chem. Soc. 2004. V.126. P.722–723.
  • Hartig J.S., Najifi-Shoushtari S.H., Grune I., Yan A., Ellington A.D., Famulok M. Protein-dependent ribozymes report molecular interactions in real time // Nat. Biotechnol. 2002. V.20. P.717–722.
  • Harvey I., Garneau P., Pelletier J. Inhibition of translation by RNA-small molecule interactions // RNA. 2002. V.8. P.452–463.
  • Hay B., Barry R.A., Lieberburg I., Prusiner S.B., Lingappa V.R. Biogenesis and transmembrane orientation of the cellular isoform of the scrapie prion protein // Mol. Cell Biol. 1987. V.2. P.914–920.
  • Heim R., Tsien R.Y. Engineering green fluorescent protein for improved brightness longer // Curr. Biol. 1996. V.6. P.178-182.
  • Held D.M., Greathouse S.T., Agrawal A., Burke D.H. Evolutionary landscapes for the acquisition of new ligand recognition by RNA aptamers // J. Mol. Evol. 2003. V.57. P.299-308.
  • Helm M., Petermeier M., Ge B., Fiammengo R., Jäschke A. Allosterically activated Diels-Alder catalysis by a ribozyme // J. Am. Chem. Soc. 2005. V.127. P.10492–10493.
  • Helmling S., Maasch C., Eulberg D., Buchner K., Schroder W., Lange C., Vonhoff S., Wlotzka B., Tschop M.H., Rosewicz S., Klussmann S. Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer // Proc. Natl. Acad. Sci. USA. 2004. V.101. P.13174-13179.
  • Hermann T. Chemical and functional diversity of small molecule ligands for RNA // Biopolymers. 2003. V.70. P.4-18.
  • Hermann T., Patel D.J. // J. Mol. Biol. 1999. V.294. P.825.
  • 10. Hermann T., Patel D.J. Biochemistry—Adaptive recognition by nucleic acid aptamers // Science. 2000. V.287. P.820–825.
  • Hermann T., Westhof E. // J. Med. Chem. 1999. V.42. P.1250.
  • Hermann T., Westhof E. // Biopolymers: Nucleic Acid Sci. 1998. V.48. P.155.
  • Hermann T., Westhof E. // J. Mol. Biol. 1998. V.276. P.903.
  • Hermann T., Westhof E. // Chem. Biol. 1999. V.6. P.R335.
  • Hertel K.J., Herschlag D., Uhlenbeck O.C. A kinetic and thermodynamic framework for the hammerhead ribozyme reaction // Biochemistry. 1994. V.33. P.3374–3385.
  • Hesselberth J.R., Miller D., Robertus J., Ellington A.D. In vitro selection of RNA molecules that inhibit the activity of ricin A-chain // J. Biol. Chem. 2000. V.275. P.4937–4942.
  • Hesselberth J.R., Robertson M.P., Knudsen S.M., Ellington A.D. Simultaneous detection of diverse analytes with an aptazyme ligase array // Anal. Biochem. 2003. V.312. P.106–112.
  • Heus H.A., Pardi A. // Science. 1991. V.253. P.191.
  • Hicke B.J., Marion C., Chang Y.-F., Gould T., Lynott C.K., Parma D., Schmidt P.G., Warren S. Tenascin-C aptamers are generated using tumor cells and purified protein // J. Biol. Chem. 2001. V.276. P.48644–48654.
  • Hicke B.J., Stephens A.W. Escort aptamers: a delivery service for diagnosis and therapy // J. Clin. Invest. 2000. V.106. P.923–928.
  • Hicke B.J., Watson S.R., Koenig A., Lynott C.K., Bargatze R.F., Chang Y.F., Ringquist S., Moon-McDermott L., Jennings S., Fitzwater T., Han H.L., Varki N., Albinana I., Willis M.C., Varki A., Parma D. DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice // J. Clin. Invest. 1996. V.98. P.2688-2692.
  • Hilger S., Willis M.C., Wolters M., Pieken W.A. Tc-99m-labeling of modified RNA // Nucleosides Nucleotides. 1999. V.18. P.1479–1481.
  • Hilger S., Willis M.C., Wolters M., Pieken W.A. Synthesis of Tc-99m labelled, modified RNA // Tetrahedron Lett. 1998. V.39. P.9403–9406.
  • Hilger C.S., Willis M.C., Wolters M., Pieken W.A. Tc-99m labeling of modified RNA // Nicolini M. and Mazzi U., Eds. Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine. SG Editoriali, Padova, V.5, 1999. P.557–560.
  • Hirao I., Harada Y., Nojima T., Osawa Y., Masaki H., Yokoyama S. In vitro selection of RNA aptamers that bind to colicin E3 and structurally resemble the decoding site of 16S ribosomal RNA // Biochemistry. 2004. V.43. P.3214-3221.
  • Hirao I., Madin K., Endo Y., Yokoyama S., Ellington A.D. RNA aptamers that bind to and inhibit the ribosome-inactivating protein, pepocin // J. Biol. Chem. 2000. V.275. P.4943-4948.
  • Hirao I., Spingola M., Peabody D., Ellington A.D. The limits of specificity: An experimental analysis with RNA aptamers to MS2 coat protein variants // Mol. Divers. 1998. V.4. P.75–89.
  • Hoadley K.A., Purtha W.E., Wolf A.C., Flynn-Charlebois A., Silverman S.K. Zn2+-Dependent Deoxyribozymes That Form Natural and Unnatural RNA Linkages // Biochemistry. 2005. V.44. P.9217-9231.
  • Hodgson D.R., Suga H. Mechanistic studies on acyl-transferase ribozymes and beyond // Biopolymers. 2004. V.73. P.130–150.
  • Hoffmann B., Mitchell G.T., Gendron P., Major F., Andersen A.A., Collins R.A., Legault P. NMR structure of the active conformation of the Varkud satellite ribozyme cleavage site // Proc. Natl. Acad. Sci. 2003. V.100. P.7003–7008.
  • Hofmann H.P., Limmer S., Hornung V., Sprinzl M. Ni2+-binding RNA motifs with an asymmetric purine-rich internal loop and a G-A base pair // RNA. 1997. V.3. P.1289-1300.
  • Holeman L.A., Robinson S.L., Szostak J.W., Wilson C. Isolation and characterization of fluorophore-binding RNA aptamers // Fold. Des. 1998. V.3. P.423-431.
  • Homann M., Göringer H.U. Combinatorial selection of high affinity RNA ligands to live African trypanosomes // Nucleic Acids Res. 1999. V.27. P.2006–2014.
  • Homann M., Lorger M., Engstler M., Zacharias M., Göringer H.U. Serum-stable RNA aptamers to an invariant surface domain of live African trypanosomes // Comb. Chem. High Throughput Screen. 2006. V.9. P.491–499.
  • Hoogstraten C.G., Legault P., Pardi A. NMR solution structure of the lead-dependent ribozyme: evidence for dynamics in RNA catalysis // J. Mol. Biol. 1998. V.284. P.337-350.
  • Hook B., Bernstein D., Zhang B., Wickens M. RNA–protein interactions in the yeast three-hybrid system: Affinity, sensitivity, and enhanced library screening // RNA. 2005. V.11. P.227–233.
  • Hormes R., Sczakiel G. The size of hammerhead ribozymes is related to cleavage kinetics: the role of substrate length // Biochimie. 2002. V.84. P.897–903.
  • Horn W.T., Convery M.A., Stonehouse N.J., Adams C.J., Liljas L., Phillips S.E., Stockley P.G. The crystal structure of a high affinity RNA stem-loop complexed with the bacteriophage MS2 capsid: further challenges in the modeling of ligand-RNA interactions // RNA. 2004. V.10. P.1776-1782.
  • Hornung V., Hofmann H.P., Sprinzl M. In vitro selected RNA molecules that bind to elongation factor Tu // Biochemistry. 1998. V.37. P.7260–7267.
  • Hoshika S., Minakawa N., Matsuda A. Synthesis and physical and physiological properties of 4'-thioRNA: application to post-modification of RNA aptamer toward NF-{kappa}B // Nucleic Acids Res. 2004. V.32. P.3815-3825.
  • Howard E.L., Becker K.C.D., Rusconi C.P., Becker R.C. Factor IXa Inhibitors as Novel Anticoagulants // Arterioscler. Thromb. Vasc. Biol. 2007. V.27. P.722-727. | | 
  • Hsiung C., Patel D.J. // Nat. Struct. Biol. 1996. V.3. P.1046–1050.
  • Huang F., Bugg C.W., Yarus M. RNA-Catalyzed CoA, NAD, and FAD synthesis from phosphopantetheine, NMN, and FMN // Biochemistry. 2000. V.39. P.15548-15555.
  • Huang F., Yang Z., Yarus M. RNA enzymes with two small-molecule substrates // Chem. Biol. 1998. V.5. P.669–678.
  • Huang F., Yarus M. 5'-RNA self-capping from guanosine diphosphate // Biochemistry. 1997. V.36. P.6557-6563.
  • Huang Z., Szostak J.W. Evolution of aptamers with a new specificity and new secondary structures from an ATP aptamer // RNA. 2003. V.9. P.1456-1463.
  • Huizenga D.E., Szostak J.W. A DNA aptamer that binds adenosine and ATP // Biochemistry. 1995. V.34. P.656–665.
  • Hwang B., Cho J.S., Yeo H.J., Kim J.H., Chung K.M., Han K., Jang S.K., Lee S.W. Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus // RNA. 2004. V.10. P.1277–1290.
  • Hwang B., Lee S.W. Improvement of RNA aptamer activity against myasthenic autoantibodies by extended sequence selection // Biochem. Biophys. Res. Commun. 2002. V.290. P.656-662.
  • Hwang J., Fauzi H., Fukuda K., Sekiya S., Kakiuchi N., Shimotohno K., Taira K., Kusakabe I., Nishikawa S. The RNA aptamer-binding site of hepatitis C virus NS3 protease // Biochem. Biophys. Res. Commun. 2000. V.279. P.557–562.
  • Hwang J., Nishikawa S. Novel Approach to Analyzing RNA Aptamer-Protein Interactions: Toward Further Applications of Aptamers // J. Biomol. Screen. 2006. V.11. P.599-605.
  • Hybarger G., Bynum J., Williams R.F., Valdes J.J., Chambers J.P. A microfluidic SELEX prototype // Anal. Bioanal. Chem. 2006. V.384. P.191-198.
  • Jagannathan V., Roulet E., Delorenzi M., Bucher P. HTPSELEX--a database of high-throughput SELEX libraries for transcription factor binding sites // Nucleic Acids Res. 2006. V.34. P.D90-D94.
  • James W. Aptamers in the virologists' toolkit // J. Gen. Virol. 2007. V.88. P.351-364.
  • Jarosch F., Buchner K., Klussmann S. In vitro selection using a dual RNA library that allows primerless selection // Nucleic Acids Res. 2006. V.34. P.e86.
  • 4. Jäschke A. Artificial ribozymes and deoxyribozymes // Curr. Opin. Struct. Biol. 2001. V.11. P.321–326.
  • Jaschke A., Seelig B. Evolution of DNA and RNA as catalysts for chemical reactions // Curr. Opin. Struct. Biol. 2000. V.4. P.257–262.
  • Jayasena S.D. Aptamers: an emerging class of molecules that rival antibodies in diagnostics // Clin. Chem. 1999. V.45. P.1628–1650.
  • Jayasena V.K., Gold L. In vitro selection of self-cleaving RNAs with a low pH optimum // Proc. Natl. Acad. Sci. USA. 1997. V.94. P.10612-10617.
  • Jellinek D., Green L.S., Bell C., Janjic N. Inhibition of receptor-binding by high-affinity RNA ligands to vascular endothelial growth-factor // Biochemistry. 1994. V.33. P.10450–10456.
  • Jellinek D., Green L.S., Bell C., Lynott C.K., Gill N., Vargeese C., Kirschenreuter G., McGee D.P., Abesinghe P., Pieken W.A., Shapiro R., Rifkin D.B., Moscatelli D., Janjic N. Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor // Biochemistry. 1995. V.34. P.11363–11372.
  • Jenison R.D., Gill S.C., Pardi A., Polisky B. High-resolution molecular discrimination by RNA // Science. 1994. V.263. P.1425–1429.
  • Jenison R.D., Jennings S.D., Walker D.W., Bargatze R.F., Parma D. Oligonucleotide inhibitors of P-selectin-dependent neutrophil-platelet adhesion // Antisense Nucleic Acid Drug Dev. 1998. V.8. P.265-279.
  • Jenne A., Famulok M. A novel ribozyme with ester transferase activity // Chem. Biol. 1998. V.5. P.23-34.
  • Jensen K.B., Atkinson B.L., Willis M.C., Koch T.H., Gold L. Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands // Proc. Natl. Acad. Sci. USA. 1995. V.92. P.12220-12224.
  • Jeon S. H., Kayhan B., Ben-Yedidia T., Arnon R. A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin // J. Biol. Chem. 2004. V.279. P.48410–48419.
  • Jeong S., Eom T., Kim S., Lee S., Yu J. In vitro selection of the RNA aptamer against the Sialyl Lewis X and its inhibition of the cell adhesion // Biochem. Biophys. Res. Commun. 2001. V.281. P.237–243.
  • Jepsen J.S., Wengel J. LNA-antisense rivals siRNA for gene silencing // Curr. Opin. Drug Discov. Devel. 2004. V.7. P.188–194.
  • Jhaveri S., Rajendran M., Ellington A.D. In vitro selection of signaling aptamers // Nat. Biotechnol. 2000. V.18. P.1293–1297.
  • Jiang F., Kumar R.A., Jones R.A., Patel D.J. Structural basis of RNA folding and recognition in an AMP–RNA aptamer complex // Nature. 1996. V.382. P.183–186.
  • Jiang F., et al. // Structure Fold. Des. 1991. V.7. P.1461.
  • Jiang L.C., Majumdar A., Hu W.D., Jaishree T.J., Xu W.K., Patel D.J. Saccharide-RNA recognition in a complex formed between neomycin B and an RNA aptamer // Structure Fold. Des. 1999. V.7. P.817–827.
  • Jiang L., Patel D.J. Solution structure of the tobramycin-RNA aptamer complex // Nature Struct. Biol. 1998. V.5. P.769–774.
  • Jiang L., Suri A.K., Fiala R., Patel D.J. Saccharide-RNA recognition in an aminoglycoside antibiotic-RNA aptamer complex // Chem. Biol. 1997. V.4. P.35.
  • Jiang Y., Wang J., Fang X., Bai C. Study of the effect of metal ion on the specific interaction between protein and aptamer by atomic force microscopy // J. Nanosci. Nanotechnol. 2004. V.4. P.611–615.
  • Jiang Y., Zhu C., Ling L., Wan L., Fang X., Bai C. Specific aptamer-protein interaction studied by atomic force microscopy // Anal. Chem. 2003. V.75. P.2112-2116.
  • Johns G.C., Joyce G.F. The promise and peril of continuous in vitro evolution // J. Mol. Evol. 2005. V.61. P.253-263.
  • Johnson S.C., Sherrill C.B., Marshall D.J., Moser M.J., Prudent J.R. A third base pair for the polymerase chain reaction: inserting isoC and isoG // Nucleic Acids Res. 2004. V.32. P.1937-1941.
  • Johnston W.K., Unrau P.J., Lawrence M.S., Glasner M.E., Bartel D.P. RNACatalyzed RNA Polymerization: Accurate and General RNA-Templated Primer Extension // Science. 2001. V.292. P.1319-1325.
  • Jose A.M., Soukup G.A., Breaker R.R. Cooperative binding of effectors by an allosteric ribozyme // Nucleic Acids Res. 2001. V.29. P.1631-1637.
  • Joyce G.F. Directed Evolution of Nucleic Acid Enzymes // Annu. Rev. Biochem. 2004. V.73. P.791-836.
  • 12. Joyce G.F. // Curr. Opin. Struct. Biol. 1994. V.4. P.331.
  • Jucker F.M., Phillips R.M., McCallum S.A., Pardi A. Role of a heterogeneous free state in the formation of a specific RNA-theophylline complex // Biochemistry. 2003. V.42. P.2560-2567.
  • Juliano R.L., Astriab-Fisher A., Falke D. Macromolecular Therapeutics: Emerging Strategies for Drug Discovery in the Postgenome Era // Mol. Interv. 2001. V.1. P.40-53.
  • Ikebukuro K., Okumura Y., Sumikura K., Karube I. A novel method of screening thrombin-inhibiting DNA aptamers using an evolution-mimicking algorithm // Nucleic Acids Res. 2005. V.33. P.e108.
  • Illangasekare M., Sanchez G., Nickles T., Yarus M. Aminoacyl-RNA synthesis catalyzed by an RNA // Science. 1995. V.267. P.643–647.
  • Illangasekare M., Yarus M. Specific, rapid synthesis of Phe-RNA by RNA // Proc. Natl. Acad. Sci. USA. 1999. V.96. P.5470-5475.
  • Illangasekare M., Yarus M. A tiny RNA that catalyzes both aminoacyl-RNA and peptidyl-RNA synthesis // RNA. 1999. V.5. P.1482-1489.
  • Ireson C.R., Kelland L.R. Discovery and development of anticancer aptamers // Mol. Cancer Ther. 2006. V.5. P.2957-2962.
  • Isaacs F.J., Dwyer D.J., Collins J.J. // Nat. Biotechnol. 2006. V.24. P.545–554.
  • Isaacs F.J., Dwyer D.J., Ding C., Pervouchine D.D., Cantor C.R., Collins J.J. Engineered riboregulators enable post-transcriptional control of gene expression // Nat. Biotechnol. 2004. V.22. P.841–847.
  • Iyo M., Kawasaki H., Taira K. Allosterically controllable maxizymes for molecular gene therapy // Curr. Opin. Mol. Ther. 2002. V.4. P.154–165.
  • Iyo M., Kawasaki H., Taira K. Maxizyme technology // Methods Mol. Biol. 2004. V.252. P.257–265.
  • Kang Y., Bogerd H.P., Yang J., Cullen B.R. Analysis of the RNA binding specificity of the human Tap protein, a constitutive transport element-specific nuclear RNA export factor // Virology. 1999. V.262. P.200–209.
  • Katilius E., Flores C., Woodbury N.W. Exploring the sequence space of a DNA aptamer using microarrays // Nucleic Acids Res. 2007. V.35. P.7626-7635.
  • Kato T., Takemura T., Yano K., Ikebukuro K., Karube I. In vitro selection of DNA aptamers which bind to cholic acid. Biochim // Biochim. Biophys. Acta. 2000. V.1493. P.12-18.
  • Kato T., Yano K., Ikebukuro K., Karube I. Interaction of three-way DNA junctions with steroids // Nucleic Acids Research. 2000. V.28. P.1963-1968.
  • Kato Y., Minakawa N., Komatsu Y., Kamiya H., Ogawa N., Harashima H., Matsuda A. New NTP analogs: the synthesis of 4'-thioUTP and 4'-thioCTP and their utility for SELEX // Nucleic Acids Res. 2005. V.33. P.2942-2951.
  • Kawakami J., Imanaka H., Yokota Y., Sugimoto N. In vitro selection of aptamers that act with Zn2+ // J. Inorg. Biochem. 2000. V.82. P.197-206.
  • Keiper S., Vyle J.S. Reversible photocontrol of deoxyribozyme-catalyzed RNA cleavage under multiple-turnover conditions // Angew. Chem. Int. Ed. 2006. V.45. P.3306-3309.
  • Kelly J.A., Feigon J., Yeates T.O. Reconciliation of the X-ray and NMR structures of the thrombin-binding aptamer d(GGTTGGTGTGGTTGG) // J. Mol. Biol. 1996. V.256. P.417-422.
  • Kertsburg A., Soukup G.A. A versatile communication module for controlling RNA folding and catalysis // Nucleic Acids Res. 2002. V.30. P.4599-4606.
  • Khati M., Schuman M., Ibrahim J., Sattentau Q., Gordon S., James W. Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamers // J. Virol. 2003. V.77. P.12692-12698.
  • Kheradpour P., Stark A., Roy S., Kellis M. Reliable prediction of regulator targets using 12 Drosophila genomes // Genome Res. 2007. V.17. P.1919-1931.
  • Khvorova A., Lescoute A., Westhof E., Jayasena S.D. // Nat. Struct. Biol. 2003. V.10. P.708–712.
  • Kiga D., Futamura Y., Sakamoto K., Yokoyama S. An RNA aptamer to the xanthine/guanine base with a distinctive mode of purine recognition // Nucleic Acids Res. 1998. V.26. P.1755–1760.
  • Kikuchi K., Umehara T., Fukuda K., Hwang J., Kuno A., Hasegawa T., Nishikawa S. RNA aptamers targeted to domain II of hepatitis C virus IRES that bind to its apical loop region // J. Biochem. 2003. V.133. P.263–270.
  • Kikuchi K., Umehara T., Fukuda K., Kuno A., Hasegawa T., Nishikawa S. A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId // Nucleic Acids Res. 2005. V.33. P.683-692.
  • Kim Y., Cao Z., Tan W. Molecular assembly for high-performance bivalent nucleic acid inhibitor // PNAS. 2008. V.105. P. 5664-5669.
  • Kim Y.M., Choi K.H., Jang Y.J., Yu J., Jeong S. Specific modulation of the anti-DNA autoantibody-nucleic acids interaction by the high affinity RNA aptamer // Biochem. Biophys. Res. Commun. 2003. V.300. P.516-523.
  • Kim N., Gan H.H., Schlick T.